Literature DB >> 11689569

Biochemical analysis of a missense mutation in aceruloplasminemia.

Nathan E Hellman1, Satoshi Kono, Hiroaki Miyajima, Jonathan D Gitlin.   

Abstract

Aceruloplasminemia is an inherited neurodegenerative disease characterized by parenchymal iron accumulation secondary to loss-of-function mutations in the ceruloplasmin gene. To elucidate the molecular pathogenesis of aceruloplasminemia, the biosynthesis of a missense mutant ceruloplasmin (P177R) occurring in an affected patient was examined. Chinese hamster ovary cells transfected with cDNAs encoding secreted and glycosylphosphatidylinositol (GPI)-linked wild-type or P177R human ceruloplasmin were examined by pulse-chase metabolic labeling. These experiments, as well as immunofluorescent analysis and N-linked glycosylation studies, indicate that both the secreted and GPI-linked forms of the P177R mutant are retained in the endoplasmic reticulum (ER). The P177R mutation resides within a novel motif, which is repeated six times in human ceruloplasmin and is conserved in the homologous proteins hephaestin and factor VIII. Analysis of additional mutations in these motifs suggests a critical role for this region in ceruloplasmin trafficking and indicates that substitution of the arginine residue is critical to the ER retention of the P177R mutant. Metabolic labeling of transfected Chinese hamster ovary cells with (64)Cu indicates that the P177R mutant is retained in the ER as an apoprotein and that copper is incorporated into both secreted and GPI-linked ceruloplasmin as a late event in the secretory pathway. Taken together, these studies reveal new insights into the determinants of holoceruloplasmin biosynthesis and indicate that aceruloplasminemia can result from retention of mutant ceruloplasmin within the early secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689569     DOI: 10.1074/jbc.M109123200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.

Authors:  Satoshi Kono; Hitoshi Suzuki; Toshiaki Oda; Hiroaki Miyajima; Yoshitomo Takahashi; Kentaro Shirakawa; Kuniko Ishikawa; Masatoshi Kitagawa
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

3.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

4.  Oxidative stress and major depression.

Authors:  Ashutosh Bajpai; Akhilesh Kumar Verma; Mona Srivastava; Ragini Srivastava
Journal:  J Clin Diagn Res       Date:  2014-12-05

5.  Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Authors:  R Mariani; C Arosio; S Pelucchi; M Grisoli; A Piga; P Trombini; A Piperno
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 6.  Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review.

Authors:  Majid Alfadhel; Amir Babiker
Journal:  Sudan J Paediatr       Date:  2018

7.  Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells.

Authors:  Julia E Maxson; Caroline A Enns; An-Sheng Zhang
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113

Review 8.  Multi-copper oxidases and human iron metabolism.

Authors:  Ganna Vashchenko; Ross T A MacGillivray
Journal:  Nutrients       Date:  2013-06-27       Impact factor: 5.717

Review 9.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Authors:  Sonia Levi; Dario Finazzi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

Review 10.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.